tiprankstipranks
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF

Cardiff Oncology (CRDF) Financial Statements

1,409 Followers

Cardiff Oncology Financial Overview

Cardiff Oncology's market cap is currently ―. The company's EPS TTM is $-0.928; its P/E ratio is -6.20; Cardiff Oncology is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 156.00K$ 141.00K$ 108.00K$ 83.00K$ 128.00K
Gross Profit$ 156.00K$ 141.00K$ 108.00K$ 83.00K$ 128.00K
EBIT$ -9.34M$ -9.73M$ -11.15M$ -11.22M$ -10.28M
EBITDA$ -9.44M$ -9.94M$ -11.29M$ -11.30M$ -10.23M
Net Income Common Stockholders$ -9.34M$ -9.74M$ -11.16M$ -11.23M$ -8.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 74.82M$ 81.36M$ 89.43M$ 96.97M$ 105.27M
Total Assets$ 81.64M$ 88.45M$ 97.45M$ 106.55M$ 116.19M
Total Debt$ 2.15M$ 2.29M$ 2.44M$ 2.58M$ 2.71M
Net Debt$ -72.67M$ -79.07M$ -86.99M$ -94.39M$ -102.55M
Total Liabilities$ 11.90M$ 10.63M$ 10.88M$ 10.05M$ 116.19M
Stockholders Equity$ 69.74M$ 77.83M$ 86.58M$ 96.50M$ 106.34M
Cash Flow-
Free Cash Flow$ -7.15M$ -8.27M$ -7.38M$ -8.67M$ -9.46M
Operating Cash Flow$ -7.14M$ -7.96M$ -7.13M$ -8.66M$ -9.39M
Investing Cash Flow$ 13.56M$ 3.82M$ 11.48M$ 7.33M$ 7.02M
Financing Cash Flow-----
Currency in USD

Cardiff Oncology Earnings and Revenue History

Cardiff Oncology Debt to Assets

Cardiff Oncology Cash Flow

Cardiff Oncology Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis